Purpose Anti-inflammation is essential for dry eye disease. Traditional anti-inflammation
agent corticosteroids applied in dry eye disease (DED) treatment could result in high …

Abstract Background Dry Eye Disease (DED) is a prevalent multifactorial ocular disease
characterized by a vicious cycle of inflammation, oxidative stress, and mitochondrial …

Dry eye disease (DED) is a common and frequent ocular surface disease worldwide, which
can cause severe ocular surface discomfort and blurred vision. Inflammation and reactive …

Oxidative stress plays a central role in dry eye disease (DED), which can destroy the mucin
layer on the ocular surface. The currently available eye drops are palliative and short-lived …

Fluorometholone (FMT) is a frequently prescribed drug for the alleviation of dry eye.
However, due to low aqueous solubility, it has been routinely used as an ophthalmic …

Eye drops are ophthalmic formulations routinely used to treat dry eye. However, the low
ocular bioavailability is an obvious drawback of eye drops owing to short ocular retention …

Dry eye disease is a multifactorial dysfunction of the tear film and ocular surface, with
etiology involving inflammation and oxidative stress on the ocular surface. Pterostilbene …

Background Dry eye disease (DED) is a commonly reported ocular complaint that has
garnered significant attention in recent research. The global occurrence of DED ranges from …

Dry eye disease (DED) or keratoconjunctivitis sicca is a chronic multifactorial disorder of the
ocular surface caused by tear film dysfunction. Symptoms include dryness, irritation …

Dry eye disease (DED) incidence is continuously growing, positioning it to become an
emergent health issue over the next few years. Several topical treatments are commonly …